TLR3 is essential for the induction of protective immunity against Punta Toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C):: Differential, recognition of synthetic dsRNA molecules

被引:95
作者
Gowen, Brian B.
Wong, Min-Hui
Jung, Kie-Hoon
Sanders, Andrew B.
Mitchell, William M.
Alexopoulou, Lena
Flavell, Richard A.
Sidwell, Robert W.
机构
[1] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA
[3] CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France
[4] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA
关键词
D O I
10.4049/jimmunol.178.8.5200
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
In the wake of RNA virus infections, dsRNA intermediates are often generated. These viral pathogen-associated molecular patterns can be sensed by a growing number of host cell cytosolic proteins and TLR3, which contribute to the induction of antiviral defenses. Recent evidence indicates that melanoma differentiation-associated gene-5 is the prominent host component mediating IFN production after exposure to the dsRNA analog, poly(I:C). We have previously reported that Punta Toro virus (PTV) infection in mice is exquisitely sensitive to treatment with poly(I:C12U), a dsRNA analog that has a superior safety profile while maintaining the beneficial activity of the parental poly(I:C) in the induction of innate immune responses. The precise host factor(s) mediating protective immunity following its administration remain to be elucidated. To assess the role of TLR3 in this process, mice lacking the receptor were used to investigate the induction of protective immunity, type I IFNs, and IL-6 following treatment. Unlike wild-type mice, those lacking TLR3 were not protected against PTV infection following poly(I:C12U) therapy and failed to produce IFN-alpha, IFN-beta, and IL-6. In contrast, poly(I:C) treatment significantly protected TLR3(-/-) mice from lethal challenge despite some deficiencies in cytokine induction. There was no indication that the lack of protection was due to the fact that TLR3-deficient mice had a reduced capacity to fight infection because they were not found to be more susceptible to PTV. We conclude that. TLR3 is essential to the induction of antiviral activity elicited by poly(I:C12U), which does not appear to be recognized by the cytosolic sensor of poly(I:C), melanoma differentiation-associated gene-5.
引用
收藏
页码:5200 / 5208
页数:9
相关论文
共 46 条
[1]
Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]
PATHOGENESIS OF A PHLEBOVIRAL INFECTION (PUNTA TORO VIRUS) IN GOLDEN SYRIAN-HAMSTERS [J].
ANDERSON, GW ;
SLAYTER, MV ;
HALL, W ;
PETERS, CJ .
ARCHIVES OF VIROLOGY, 1990, 114 (3-4) :203-212
[4]
The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter [J].
Andrejeva, J ;
Childs, KS ;
Young, DF ;
Carlos, TS ;
Stock, N ;
Goodbourn, S ;
Randall, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17264-17269
[5]
Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways [J].
Barchet, W ;
Krug, A ;
Cella, M ;
Newby, C ;
Fischer, JAA ;
Dzionek, A ;
Pekosz, A ;
Colonna, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) :236-242
[6]
The dsRNA binding site of human toll-like receptor 3 [J].
Bell, Jessica K. ;
Askins, Janine ;
Hall, Pamela R. ;
Davies, David R. ;
Segal, David M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (23) :8792-8797
[7]
CARTER WA, 1987, LANCET, V1, P1286
[8]
STRUCTURAL REQUIREMENTS OF RIN.RCN COMPLEX FOR INDUCTION OF HUMAN INTERFERON [J].
CARTER, WA ;
MARSHALL, LW ;
TSO, POP ;
TAZAWA, S ;
TAZAWA, I ;
PITHA, PM .
JOURNAL OF MOLECULAR BIOLOGY, 1972, 70 (03) :567-&
[9]
CARTER WA, 1976, MOL PHARMACOL, V12, P440
[10]
Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253